Receptor‐mediated clearance of factor VIII: implications for pharmacokinetic studies in individuals with haemophilia
- 18 September 2006
- journal article
- Published by Wiley in Haemophilia
- Vol. 12 (s4), 15-22
- https://doi.org/10.1111/j.1365-2516.2006.01329.x
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- LDL receptor cooperates with LDL receptor–related protein in regulating plasma levels of coagulation factor VIII in vivoBlood, 2005
- Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohortBritish Journal of Haematology, 2004
- Clearance of coagulation factor VIII in very low-density lipoprotein receptor knockout miceBritish Journal of Haematology, 2004
- Treating haemophilia A with recombinant blood factors: a comparisonExpert Opinion on Pharmacotherapy, 2004
- Factor VIII expression in liver diseaseThrombosis and Haemostasis, 2004
- Low Density Lipoprotein Receptor-related Protein and Factor IXa Share Structural Requirements for Binding to the A3 Domain of Coagulation Factor VIIIPublished by Elsevier ,2003
- Pharmacokinetics of Coagulation FactorsClinical Pharmacokinetics, 2001
- Interaction Between Factor VIII and LDL Receptor-related Protein Modulation of Coagulation?Trends in Cardiovascular Medicine, 2000
- The Sequence Glu1811-Lys1818 of Human Blood Coagulation Factor VIII Comprises a Binding Site for Activated Factor IXPublished by Elsevier ,1996
- Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type IIIAnnals of Hematology, 1992